Novel autoantibodies and clinical phenotypes in adult and juvenile myositis
Related documents:This repository does not currently have the full-text of this item.
You may be able to access a copy if URLs are provided below. (Contact Author)
Autoantibodies targeting intracellular proteins involved in key processes are detected in patients with idiopathic inflammatory myopathies. These myositisspecific autoantibodies have been increasingly demonstrated to correlate with distinct clinical phenotypes within the myositis spectrum. This review highlights the clinical associations of the myositisspecific autoantibodies, with particular attention to the recently identified and characterized novel myositis autoantibodies: p155/140, p140 (MJ), CADM-140 (MDA5), SAE, and 200/100.
|Creators||Betteridge, Z. E., Gunawardena, H. and McHugh, N. J.|
|Departments||Faculty of Science > Pharmacy & Pharmacology|
Faculty of Humanities & Social Sciences > Health
Actions (login required)